Search
2023 Volume 3
Article Contents
REVIEW   Open Access    

Edible mushroom: occurrence, management and health benefits

More Information
  • Owing to medicinal and nutraceutical properties, mushrooms have been consumed worldwide for many years. They are valued for their unique flavor, texture, and versatility in cooking. Numerous species of edible mushrooms have different habitats, ecological niches, and growth patterns. In a vegetarian diet, mushrooms have been preferred and widely accepted over a non-vegetarian one because of their low-calorie, high-protein content and their good source of carbohydrates and lipids. Edible mushrooms provide various macronutrients, micronutrients, minerals, and vitamins. Bioactive compounds extracted from different species of mushrooms exhibit various medicinal properties, such as antitumor, antioxidant, hypocholesterolemic, antiallergic, anti-inflammatory, and hypoglycemic effects. These properties are mainly due to polysaccharides like β-glucan, polyphenols like phenolic acids and flavonoids, carotenoids, and vitamins. Edible mushrooms are also potential prebiotics and are beneficial for human gut health. Secondary metabolites extracted from edible mushrooms are used to develop drugs to treat chronic diseases.
    In conclusion, edible mushrooms contain essential food supplements and versatile food sources that provide numerous health benefits. Effective management of edible mushroom production is crucial to ensure their continued availability, quality, and sustainability. The study of edible mushrooms and their health benefits continues to be an area of active research, and additional benefits will likely be further discovered.
  • 加载中
  • [1]

    Bishop KS, Kao CHJ, Xu Y, Glucina MP, Paterson RRM, et al. 2015. From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114:56−65

    doi: 10.1016/j.phytochem.2015.02.015

    CrossRef   Google Scholar

    [2]

    Guggenheim AG, Wright KM, Zwickey HL. 2014. Immune modulation from five major mushrooms: application to integrative oncology. Integrative Medicine: Clinician’s Journal 13:32−44

    Google Scholar

    [3]

    Chaturvedi VK, Agarwal S, Gupta KK, Ramteke PW, Singh MP. 2018. Medicinal mushroom: boon for therapeutic applications. 3 Biotech 8:334

    doi: 10.1007/s13205-018-1358-0

    CrossRef   Google Scholar

    [4]

    Gáper J, Gáperová S, Pristas P, Naplavova K. 2016. Medicinal value and taxonomy of the tinder polypore, Fomes fomentarius (Agaricomycetes): a review. International Journal of Medicinal Mushrooms 18:851−59

    doi: 10.1615/IntJMedMushrooms.v18.i10.10

    CrossRef   Google Scholar

    [5]

    El-Ramady H, Abdalla N, Badgar K, Llanaj X, Törős G, et al. 2022. Edible mushrooms for sustainable and healthy human food: Nutritional and medicinal attributes. Sustainability 14:4941

    doi: 10.3390/su14094941

    CrossRef   Google Scholar

    [6]

    Cheute VMS, Backes E, Corrêa RCG, Corrêa VG, Bracht A, et al. 2022. The global market for mushrooms, their uses as dietary supplements and associated safety issues. In Edible Fungi: Chemical Composition, Nutrition and Health Effects, eds. Stojković D, Barros L. UK: Royal Society of Chemistry. pp. 383−93. https://doi.org/10.1039/9781839167522

    [7]

    Thakur MP. 2014. Present status and future prospects of tropical mushroom cultivation in India: a review. Indian Phytopathology 67:113−25

    Google Scholar

    [8]

    Kalač P. 2013. A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms. Journal of the Science of Food and Agriculture 93:209−18

    doi: 10.1002/jsfa.5960

    CrossRef   Google Scholar

    [9]

    Zhong JJ, Xiao JH. 2009. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. In Biotechnology in China I: Advances in Biochemical Engineering/Biotechnology, eds. Zhong JJ, Bai FW, Zhang W. Heidelberg: Springer, Berlin. pp. 79−150. https://doi.org/10.1007/10_2008_26

    [10]

    Shirur MA, Shivalingegowda NS, Chandregowda MJ, Rana RK. 2017. Entrepreneurial behaviour and socio economic analysis of mushroom growers in Karnataka. Indian Journal of Agricultural Sciences 6:840−45

    Google Scholar

    [11]

    El-Ramady H, Abdalla N, Fawzy Z, Badgar K, Llanaj X, et al. 2022. Green biotechnology of oyster mushroom (Pleurotus ostreatus L.): A sustainable strategy for myco-remediation and bio-fermentation. Sustainability 14:3667

    doi: 10.3390/su14063667

    CrossRef   Google Scholar

    [12]

    Kapahi M. 2018. Recent advances in cultivation of edible mushrooms. In Biology of Macrofungi. Fungal Biology, eds. Singh B, Lallawmsanga, Passari A. Switzerland: Springer, Cham. pp. 275−86. https://doi.org/10.1007/978-3-030-02622-6_13

    [13]

    Ganeshpurkar A, Rai G, Jain AP. 2010. Medicinal mushrooms: Towards a new horizon. Pharmacognosy Reviews 4:127−35

    doi: 10.4103/0973-7847.70904

    CrossRef   Google Scholar

    [14]

    Keller NP. 2019. Fungal secondary metabolism: regulation, function and drug discovery. Nature Reviews Microbiology 17:167−80

    doi: 10.1038/s41579-018-0121-1

    CrossRef   Google Scholar

    [15]

    Lin CH, Sheu GT, Lin YW, Yeh CS, Huang YH, et al. 2010. A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells. Process Biochemistry 45:1537−42

    doi: 10.1016/j.procbio.2010.06.006

    CrossRef   Google Scholar

    [16]

    Patel S, Goyal A. 2012. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech 2:1−15

    doi: 10.1007/s13205-011-0036-2

    CrossRef   Google Scholar

    [17]

    Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G Jr, et al. 2016. Prebiotics: Why definitions matter. Current Opinion in Biotechnology 37:1−7

    doi: 10.1016/j.copbio.2015.09.001

    CrossRef   Google Scholar

    [18]

    Singdevsachan SK, Auroshree P, Mishra J, Baliyarsingh B, Tayung K, et al. 2016. Mushroom polysaccharides as potential prebiotics with their antitumor and immunomodulating properties: A review. Bioactive Carbohydrates and Dietary Fibre 7:1−4

    doi: 10.1016/j.bcdf.2015.11.001

    CrossRef   Google Scholar

    [19]

    Varshney J, Ooi JH, Jayarao BM, Albert I, Fisher J, et al. 2013. White button mushrooms increase microbial diversity and accelerate the resolution of Citrobacter rodentium infection in mice. The Journal of Nutrition 143:526−32

    doi: 10.3945/jn.112.171355

    CrossRef   Google Scholar

    [20]

    Meneses ME, Martínez-Carrera D, Torres N, Sánchez-Tapia M, Aguilar-López M, et al. 2016. Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 mice. PLoS One 11:e0159631

    doi: 10.1371/journal.pone.0159631

    CrossRef   Google Scholar

    [21]

    Wasser S. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology 60:258−74

    doi: 10.1007/s00253-002-1076-7

    CrossRef   Google Scholar

    [22]

    Firenzuoli F, Gori L, Lombardo G. 2008. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evidence-Based Complementary and Alternative Medicine 5:3−15

    doi: 10.1093/ecam/nem007

    CrossRef   Google Scholar

    [23]

    Zhou XW, Su KQ, Zhang YM. 2012. Applied modern biotechnology for cultivation of Ganoderma and development of their products. Applied Microbiology and Biotechnology 93:941−63

    doi: 10.1007/s00253-011-3780-7

    CrossRef   Google Scholar

    [24]

    Bobek P, Ozdín L, Galbavý Š. 1998. Dose- and time-dependent ´hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition 14:282−86

    doi: 10.1016/S0899-9007(97)00471-1

    CrossRef   Google Scholar

    [25]

    Phan CW, Wong WL, David P, Naidu M, Sabaratnam V. 2012. Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde: Nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells. BMC Complementary and Alternative Medicine 12:102

    doi: 10.1186/1472-6882-12-102

    CrossRef   Google Scholar

    [26]

    Kubo K, Aoki H, Nanba H. 1994. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake) I. Biological and Pharmaceutical Bulletin 17:1106−10

    doi: 10.1248/bpb.17.1106

    CrossRef   Google Scholar

    [27]

    Kim HM, Kang JS, Kim JY, Park SK, Kim HS, et al. 2010. Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse. International immunopharmacology 10:72−78

    doi: 10.1016/j.intimp.2009.09.024

    CrossRef   Google Scholar

    [28]

    Kumar K, Mehra R, Guiné RPF, Lima MJ, Kumar N, et al. 2021. Edible mushrooms: A comprehensive review on bioactive compounds with health benefits and processing aspects. Foods 10:2996

    doi: 10.3390/foods10122996

    CrossRef   Google Scholar

    [29]

    Hwang HJ, Kim SW, Lim JM, Joo JH, Kim HO, et al. 2005. Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroomPhellinus baumii in streptozotocin-induced diabetic rats. Life Sciences 76:3069−80

    doi: 10.1016/j.lfs.2004.12.019

    CrossRef   Google Scholar

    [30]

    Oh TW, Kim YA, Jang WJ, Byeon JI, Ryu CH, et al. 2010. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of Agricultural and Food Chemistry 58:4113−19

    doi: 10.1021/jf9036672

    CrossRef   Google Scholar

    [31]

    Genestra M. 2007. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cellular Signalling 19:1807−19

    doi: 10.1016/j.cellsig.2007.04.009

    CrossRef   Google Scholar

    [32]

    Dröge W. 2002. Free radicals in the physiological control of cell function. Review. Physiological Reviews 82:47−95

    doi: 10.1152/physrev.00018.2001

    CrossRef   Google Scholar

    [33]

    Halliwell B. 1995. How to characterize an antioxidant: An update. Biochemical Society Symposium 61:73−101

    doi: 10.1042/bss0610073

    CrossRef   Google Scholar

    [34]

    Shishodia SK, Shankar J. 2020. Exploration of mycelial proteins from Aspergillus terreus revealed ribosome biogenesis and antioxidant enzymes. Current Proteomics 17:433−45

    doi: 10.2174/1570164617666191004163734

    CrossRef   Google Scholar

    [35]

    Shankar J. 2021. Food habit associated mycobiota composition and their impact on human health. Frontiers in Nutrition 8:773577

    doi: 10.3389/fnut.2021.773577

    CrossRef   Google Scholar

    [36]

    Falch BH, Espevik T, Ryan L, Stokke BT. 2000. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydrate Research 329:587−96

    doi: 10.1016/S0008-6215(00)00222-6

    CrossRef   Google Scholar

    [37]

    Zhang M, Cui SW, Cheung PCK, Wang Q. 2007. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends in Food Science & Technology 18:4−19

    doi: 10.1016/j.jpgs.2006.07.013

    CrossRef   Google Scholar

    [38]

    Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. 2004. Polyphenols: food sources and bioavailability. The American Journal of Clinical Nutrition 79:727−47

    doi: 10.1093/ajcn/79.5.727

    CrossRef   Google Scholar

    [39]

    Ferreira ICFR, Barros L, Abreu RMV. 2009. Antioxidants in wild mushrooms. Current Medicinal Chemistry 16:1543−60

    doi: 10.2174/092986709787909587

    CrossRef   Google Scholar

    [40]

    Finley JW, Kong AN, Hintze KJ, Jeffery EH, Ji LL, et al. 2011. Antioxidants in foods: State of the science important to the food industry. Journal of Agricultural and Food Chemistry 59:6837−46

    doi: 10.1021/jf2013875

    CrossRef   Google Scholar

    [41]

    Scalbert A, Johnson IT, Saltmarsh M. 2005. Polyphenols: antioxidants and beyond. The American Journal of Clinical Nutrition 81:215S−217S

    doi: 10.1093/ajcn/81.1.215S

    CrossRef   Google Scholar

    [42]

    Sies H, Stahl W, Sundquist AR. 1992. Antioxidant functions of vitamins: Vitamins E and C, Beta-Carotene, and other carotenoids. Annals of the New York Academy of Sciences 669:7−20

    doi: 10.1111/j.1749-6632.1992.tb17085.x

    CrossRef   Google Scholar

    [43]

    Kozarski M, Klaus A, Jakovljevic D, Todorovic N, Vunduk J, et al. 2015. Antioxidants of edible mushrooms. Molecules 20:19489−525

    doi: 10.3390/molecules201019489

    CrossRef   Google Scholar

    [44]

    Barros L, Correia DM, Ferreira ICFR, Baptista P, Santos-Buelga C. 2008. Optimization of the determination of tocopherols in Agaricus sp. edible mushrooms by a normal phase liquid chromatographic method. Food Chemistry 110:1046−50

    doi: 10.1016/j.foodchem.2008.03.016

    CrossRef   Google Scholar

    [45]

    Chen SY, Ho KJ, Hsieh YJ, Wang LT, Mau JL. 2012. Contents of lovastatin, γ-aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT 47:274−78

    doi: 10.1016/j.lwt.2012.01.019

    CrossRef   Google Scholar

    [46]

    Lakshmi B, Tilak JC, Adhikari S, Devasagayam TPA, Janardhanan KK. 2005. Inhibition of lipid peroxidation induced by γ-radiation and AAPH in rat liver and brain mitochondria by mushrooms. Current Science 88:484−88

    Google Scholar

    [47]

    Figueiredo L, Régis WCB. 2017. Medicinal mushrooms in adjuvant cancer therapies: An approach to anticancer effects and presumed mechanisms of action. Nutrire 42:28

    doi: 10.1186/s41110-017-0050-1

    CrossRef   Google Scholar

    [48]

    Byerrum RU, Clarke DA, Lucas EH, Ringler RL, Stevens JA, et al. 1957. Tumor inhibitors in Boletus edulis and other Holobasidiomycetes. Antibiot Chemother 7(1):1−4

    Google Scholar

    [49]

    Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, et al. 2012. hase 1 clinical trial of Trametes versicolor in women with breast cancer. International Scholarly Research Notices 2012:251632

    doi: 10.5402/2012/251632

    CrossRef   Google Scholar

    [50]

    Zhao H, Zhang Q, Zhao L, Huang X, Wang J, et al. 2012. Spore powder of Ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: a pilot clinical trial. Evidence-Based Complementary and Alternative Medicine 2012:809614

    doi: 10.1155/2012/809614

    CrossRef   Google Scholar

    [51]

    Deng G, Lin H, Seidman A, Fornier M, D’Andrea G, et al. 2009. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients. Journal of Cancer Research and Clinical Oncology 135:1215−21

    doi: 10.1007/s00432-009-0562-z

    CrossRef   Google Scholar

    [52]

    Yamaguchi Y, Miyahara E, Hihara J. 2011. Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot study. The American Journal of Chinese Medicine 39:451−59

    doi: 10.1142/S0192415X11008956

    CrossRef   Google Scholar

    [53]

    Panda SK, Sahoo G, Swain SS, Luyten W. 2022. Anticancer activities of mushrooms: a neglected source for drug discovery. Pharmaceuticals 15:176

    doi: 10.3390/ph15020176

    CrossRef   Google Scholar

    [54]

    Fortes RC, Recôva VL, Melo AL, Novaes MRCG. 2010. Life quality of postsurgical patients with colorectal cancer after supplemented diet with Agaricus sylvaticus fungus. Nutricion Hospitalaria 25(4):586−96

    Google Scholar

    [55]

    Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, et al. 1999. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepato-gastroenterology 46(28):2662−68

    Google Scholar

    [56]

    Grinde B, Hetland G, Johnson E. 2006. Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection. International Immunopharmacology 6:1311−14

    doi: 10.1016/j.intimp.2006.04.005

    CrossRef   Google Scholar

    [57]

    Chay WY, Tham CK, Toh HC, Lim HY, Tan CK, et al. 2017. Coriolus versicolor (Yunzhi) use as therapy in advanced hepatocellular carcinoma patients with poor liver function or who are unfit for standard therapy. The Journal of Alternative and Complementary Medicine 23:648−52

    doi: 10.1089/acm.2016.0136

    CrossRef   Google Scholar

    [58]

    Yang P, Liang M, Zhang Y, Shen B. 2008. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Advances in Therapy 25:787−94

    doi: 10.1007/s12325-008-0079-x

    CrossRef   Google Scholar

    [59]

    Isoda N, Eguchi Y, Nukaya H, Hosho K, Suga Y, et al. 2009. Clinical efficacy of superfine dispersed lentinan (β-1,3-glucan) in patients with hepatocellular carcinoma. Hepato-gastroenterology 56:437−41

    Google Scholar

    [60]

    Gao Y, Dai X, Chen G, Ye J, Zhou S. 2003. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W. Curt. : Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly®) in patients with advanced lung cancer. International Journal of Medicinal Mushrooms 5:14

    doi: 10.1615/interjmedicmush.v5.i4.40

    CrossRef   Google Scholar

    [61]

    Twardowski P, Kanaya N, Frankel P, Synold T, Ruel C, et al. 2015. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus–induced prostate-specific antigen responses. Cancer 121:2942−50

    doi: 10.1002/cncr.29421

    CrossRef   Google Scholar

    [62]

    Sumiyoshi Y, Hashine K, Kakehi Y, Yoshimura K, Satou T, et al. 2010. Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study. Japanese Journal of Clinical Oncology 40:967−972

    doi: 10.1093/jjco/hyq081

    CrossRef   Google Scholar

    [63]

    deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. 2002. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 60:640−44

    doi: 10.1016/S0090-4295(02)01856-3

    CrossRef   Google Scholar

    [64]

    Yassin M, Mahajna JA. 2003. Submerged cultured mycelium extracts of higher Basidiomycetes mushrooms selectively inhibit proliferation and induce differentiation of K562 human chronic myelogenous leukemia cells. International Journal of Medicinal Mushrooms 5:16

    doi: 10.1615/interjmedicmush.v5.i3.40

    CrossRef   Google Scholar

    [65]

    Wang H, Ng TB, Ooi VEC. 1998. Lectins from mushrooms. Mycological Research 102:897−906

    doi: 10.1017/S0953756298006200

    CrossRef   Google Scholar

    [66]

    Brzin J, Rogelj B, Popovic T, Strukelj B, Ritonja A. 2000. Clitocypin, a new type of cysteine proteinase inhibitor from fruit bodies of mushroom Clitocybe nebularis. Journal of Biological Chemistry 275:20104−9

    doi: 10.1074/jbc.M001392200

    CrossRef   Google Scholar

    [67]

    Galesa K, Thomas RM, Kidric M, Pain RH. 2004. Clitocypin, a new cysteine proteinase inhibitor, is monomeric:impact on the mechanism of folding. Biochemical and Biophysical Research Communications 324:576−78

    doi: 10.1016/j.bbrc.2004.09.092

    CrossRef   Google Scholar

    [68]

    Ohta T, Inoue H, Kusano G, Oshima Y. 1998. Lepiotins A and B, new alkaloids from the mushrooms, Macrolepiota neomastoidea and Chlorophyllum molybdites. Heterocycles 2(47):883−91

    Google Scholar

    [69]

    Zaidman BZ, Yassin M, Mahajna J, Wasser SP. 2005. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Applied Microbiology and Biotechnology 67:453−68

    doi: 10.1007/s00253-004-1787-z

    CrossRef   Google Scholar

    [70]

    Poucheret P, Fons F, Rapior S. 2006. Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Cryptogamie, Mycologie 27:311−33

    Google Scholar

    [71]

    Paterson RRM. 2006. Ganoderma – a therapeutic fungal biofactory. Phytochemistry 67:1985−2001

    doi: 10.1016/j.phytochem.2006.07.004

    CrossRef   Google Scholar

    [72]

    Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA. 2007. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology 7:701−24

    doi: 10.1016/j.intimp.2007.01.008

    CrossRef   Google Scholar

    [73]

    Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ. 2006. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sciences 80:205−11

    doi: 10.1016/j.lfs.2006.09.001

    CrossRef   Google Scholar

    [74]

    Lindequist U, Niedermeyer THJ, Jülich WD. 2005. The pharmacological potential of mushrooms. Evidence-based complementary and alternative medicine 2:906016

    doi: 10.1093/ecam/neh107

    CrossRef   Google Scholar

    [75]

    Wang M, Zhao R. 2023. A review on nutritional advantages of edible mushrooms and its industrialization development situation in protein meat analogues. Journal of Future Foods 3:1−7

    doi: 10.1016/j.jfutfo.2022.09.001

    CrossRef   Google Scholar

    [76]

    Bell V, Silva CRPG, Guina J, Fernandes TH. 2022. Mushrooms as future generation healthy foods. Frontiers in Nutrition 9:1050099

    doi: 10.3389/fnut.2022.1050099

    CrossRef   Google Scholar

  • Cite this article

    Rani M, Mondal SM, Kundu P, Thakur A, Chaudhary A, et al. 2023. Edible mushroom: occurrence, management and health benefits. Food Materials Research 3:21 doi: 10.48130/FMR-2023-0021
    Rani M, Mondal SM, Kundu P, Thakur A, Chaudhary A, et al. 2023. Edible mushroom: occurrence, management and health benefits. Food Materials Research 3:21 doi: 10.48130/FMR-2023-0021

Figures(2)  /  Tables(3)

Article Metrics

Article views(4513) PDF downloads(670)

REVIEW   Open Access    

Edible mushroom: occurrence, management and health benefits

Food Materials Research  3 Article number: 21  (2023)  |  Cite this article

Abstract: 

Owing to medicinal and nutraceutical properties, mushrooms have been consumed worldwide for many years. They are valued for their unique flavor, texture, and versatility in cooking. Numerous species of edible mushrooms have different habitats, ecological niches, and growth patterns. In a vegetarian diet, mushrooms have been preferred and widely accepted over a non-vegetarian one because of their low-calorie, high-protein content and their good source of carbohydrates and lipids. Edible mushrooms provide various macronutrients, micronutrients, minerals, and vitamins. Bioactive compounds extracted from different species of mushrooms exhibit various medicinal properties, such as antitumor, antioxidant, hypocholesterolemic, antiallergic, anti-inflammatory, and hypoglycemic effects. These properties are mainly due to polysaccharides like β-glucan, polyphenols like phenolic acids and flavonoids, carotenoids, and vitamins. Edible mushrooms are also potential prebiotics and are beneficial for human gut health. Secondary metabolites extracted from edible mushrooms are used to develop drugs to treat chronic diseases.
In conclusion, edible mushrooms contain essential food supplements and versatile food sources that provide numerous health benefits. Effective management of edible mushroom production is crucial to ensure their continued availability, quality, and sustainability. The study of edible mushrooms and their health benefits continues to be an area of active research, and additional benefits will likely be further discovered.

    • Fungi have been used since ancient times to treat several medical conditions and are recently more in demand for their medicinal properties[1]. About 2.2 to 3.8 million fungi species are estimated, out of which 120,000 are accepted. Medicinal mushrooms (MMs) are primarily members of the division Basidiomycota[2]. They are filamentous fungi having reproductive structures (fruiting bodies). They show various prominent pharmacological properties to human health[3]. The edible fruiting bodies have long been enjoyed as delicacies across the world, providing a wholesome experience and nutritional properties hand in hand. Such as Fomes fomentarius has been used since 450 BCE when the Greek physician Hippocrates categorized it as a potent anti-inflammatory and cauterization agent[4].Cauterization is a medical procedure that involves removing or burning a part of the human body to prevent bleeding, infection, and undesirable growth. In North America, mushrooms from the Calvatia genus have been used to treat wounds[2].

      The increased understanding of mushrooms’ good taste, nutritional, and therapeutic properties has resulted in a surge in mushroom cultivation. Mushroom cultivation requires composting, spawning, casing, harvesting, and washing[5]. Composting involves two phases; during the first phase, different organic matters are mixed to prepare a mixture, then microflora-like molds and bacteria are allowed to ferment the mixture. During the second phase, nitrogenous compounds and ammonia are treated and converted into microbial protein. It takes approx 20−30 d. The next step is spawning which takes 14 d. During spawning, mycelium is allowed to grow by inoculating the compost. After the proper growth of mycelium, they are ready to be planted. Finally, mushrooms are harvested through various methods and preserved.

      China is the world’s largest producer and consumer of farmed edible mushrooms, producing approximately 6,675,364 tonnes per year (almost 95% of global output), compared to about 294,656 tonnes per year in the rest of Asia. The medicinal value of mushrooms and their importance may likely enhance cultivation and consumption around the world in future. While the contribution of the European Union, the United States, and other sources remained at more than 3 billion tonnes per year[6]. India ranks 14th in global mushroom output, with 60,733 tonnes of mushrooms produced annually[7]. India has diversified soil, an abundance of agro-wastes, comparatively low-cost labor, and agro-climatic conditions that are perfect for mushroom culture and growth. During the monsoon season (June–October), the high humidity creates an ideal environment for mushroom development. In India, the government encourages mushroom cultivation by offering training and subsidies through various schemes such as the National Horticulture Board, the Ministry of Food Processing, and APEDA[7]. The rise in popularity of edible mushrooms increased with the development of a new scientific discipline known as functional food science, which encompasses a variety of functional foods such as dietary supplements, foods rich in medicinal properties, vita foods consumed to improve mental and physical health, phytochemicals, mycochemicals, and pharma food, all of which are specifically designed and consumed for specific health benefits[8]. Around 30 genera with about 3000 species fall into the category of edible mushrooms, and approximately 700 are considered beneficial therapeutic mushrooms[9]. The most commonly cultivated mushroom species are shiitake (Lentinula edodes), oyster mushroom (Pleurotus spp.), white button mushroom (Agaricus bisporus), black fungus or wood-ear mushrooms (Auricularia auricula, Auricularia polytricha), and paddy straw mushroom (Volvariella spp). Increased awareness of their nutritional and medicinal qualities has fuelled demand, and they are now commercially grown and consumed worldwide[10]. They provide a good source of essential nutrients like copper (Cu), phosphorus (P), potassium (K), zinc (Zn), selenium (Se), riboflavin (vitamin B2), niacin (vitamin B3), choline, and vitamin B6 if supplemented in the consortium in regular diets[8]. . These mushrooms are considered primarily for their bioactive compounds over other foods, providing a resource material to boost the immune systems and prevent life-threatening diseases[11].

      Mushrooms, which have been appreciated for their medicinal capabilities since ancient times, have seen a spike in popularity due to their possible involvement in treating a variety of medically significant disorders. Several recent studies indicate the potential benefits of introducing mushrooms in the diet, which might help us meet the daily nutrient requirements and be beneficial in preventing severe diseases. Several species of Flammulina velutipes, Grifola frondosa, Ganoderma lucidium, Lentinula edodes, and Pleurotus ostreatus are reported to carry free radical scavenging properties that play a pivotal role in reducing the potential adverse effects of reactive oxygen species, for instance, hydroxyl radical [OH], superoxide radical [${\text{O}^-_2} $], and H2O2 carrying DNA nicking properties[3, 5]. Mushrooms like Agaricus bisporus, Flammulina velutipes, Lentinula edodes, and Pleurotus ostreatus, have been seen as an effective hypocholesterolemic agents, aiding in reducing blood cholesterol levels. These medicinal properties are ascribed to the presence of secondary metabolites (SMs), which confer medicinal mushrooms as some superfood[9]. SMs are bioactive compounds produced in response to any stress and help the host survive by signaling and defensive mechanisms. They are considered not essential for the flourishing growth and reproduction of fungi[11].

      However, the idea of SMs not being crucial for fungal survival has been challenged in recent scientific studies. Recent studies provided novel insights into these metabolites and their roles in better health. These metabolites are produced by biosynthetic gene clusters (BGCs) which are regulated in a way that is consistent and favorable for fungal development or in response to stress that can be both abiotic and biotic[11]. Thus review article focuses on the nutritional value of the mushrrom as a functional food, productivity and its application.

    • Management of mushrooms included various steps like preparation of media, inoculation, and filling of the containers, the spawn run, complete colonization, the rest period, maturation and harvesting, and initiation and pining[12] (Fig. 1). Hardwood chips, manure-based compost, and hardwood logs can be utilized as media. Inoculation of the substrate should be done and mixed into media. It majorly depends upon the cultivation location. The colonization of media is known as spawn run. This process runs for a few weeks or a few days and after that mushrooms appear. Complete colonization leads to the formation of colonized mycelia which is known as primordia. Temperature, light, and water affect the growth of primordia. It ruptures and enlarges based on these factors. After harvesting primordia growth stops or slows then it matures or enlarges[7]. The rest of the steps are important before the next flush because mycelia need proper rest for growth. Pest and disease management is done through various steps like maintaining cleanliness, use of predatory mites, and nematodes, monitoring, and integrated pest management. After harvesting and post-harvesting sorting and grading of mushrooms was done based on their size, appearance, and quality. This step is important based on market value. After packaging mushrooms are stored in a cool, humid environment that extends their shelf life[9]. Maintaining records of the cultivation process, including environmental conditions, pest and disease occurrence, and yield data improves edible mushroom management techniques and also optimizes future production[13].

      Figure 1. 

      Flow chart representing different stages of mushroom cultivation.

    • As more people switch to a vegetarian diet, mushrooms are becoming one of the choices. The essential constituents of edible mushrooms are carbohydrates, vitamins (A, B, C, D, and E), protein, minerals, and fiber. Because of their high protein content (200–250 g/kg DW), mushrooms have high pharmaceutical potential. Protein like lectins produced by edible mushrooms has various pharmaceutical properties like antibacterial, antitumoral, antifungal, and antiviral activity[14]. Different edible mushrooms also produce immunomodulatory proteins, which are used in cancer treatment as adjuvants[15]. Besides these compounds, mushrooms have many bioactive compounds like minerals, volatile oils, glycosides, carotenoids, terpenoids, alkaloids, tocopherols, flavonoids, folates, ascorbic acids, and lectins[16]. Mushrooms can also be considered as a good source of prebiotics due to their high polysaccharide content, like α- and β-glucans, chitin, mannans, galactan, and xylans[17, 18]. Prebiotics are compounds that promote the growth of friendly microorganisms in the gut that improve the overall health of their host[17].

      White button mushrooms increase and promote microbial diversity in the gut. It is also responsible for inflammatory responses and induces the production of the neurotransmitter catecholamines[19]. Reishi mushrooms (Ganoderma lucidium) can modulate the composition of microbes present in the gut and reverses dysbiosis. It also reduces inflammation and obesity. Mushrooms as prebiotics are an intense area of research[20].

    • Agarucu sblazei, A. polytricha, and A. bisporus are some of the most prominent species under the genus Agaricus. Among these, A. bisporus is the most cultivated in the entire world. Agaricus extracts have many therapeutic and medicinal properties[21]. Lectin isolated from A. bisporus and A. polytricha was reported to be very effective immunostimulants[16]. Fruiting bodies of A. blazei have antimutagenic, anticarcinogenic, and immunomodulatory properties.

      Many antioxidant compounds like phenolic compounds, β-glucans, tocopherols, and steroids are present in A. blazei. These compounds have medicinal properties and are widely used to treat various diseases including cancer, chronic hepatitis, diabetes, arteriosclerosis, and hyperlipidemia[22].

    • Also known as Lingzhi or Reishi, Ganoderma is one of the edible mushrooms with a high level of medicinal properties. China, Korea, and Japan are leading producers of this mushroom. Chinese people use this mushroom for longevity and also to treat carcinoma and hypertension. Ganoderma has many medicinal properties, like antioxidant, anti-inflammatory, antiallergic, immunomodulating, and antitumor properties[21]. This mushroom has been used in cancer treatment for centuries as polysaccharides extracted from Ganoderma possess anticancer properties. For the treatment of diabetes, and hepatitis, Ganoderma has been used as an adjuvant[23].

    • Pleurotus is popularly known as oyster mushroom. It has been used for centuries because of its medicinal properties and has been cultivated worldwide. Compounds extracted from this mushroom have many nutraceutical properties. Bobek et al. reported that oyster mushroom has anti-inflammatory properties and can be used as a functional food. Some authors also reported that oyster mushroom has a hypocholesterolemic effect on model rats with hereditary cholesterol disorders and hypercholesterolemia or cholesterolemia[24]. Pleurotus giganteus, a popular culinary mushroom, contains dietary fiber (33.3/100 g of mushroom) and 15.4 g of protein. It is also a rich source of minerals like potassium (1,345.7 mg/100 g dry weight) and magnesium (67.64 mg/100 g dry weight). Also carbohydrate content of Pleurotus giganteus is much higher than other edible mushrooms[25]. About 40 species are reported under the genus Pleurotus; some common species are P. eryngii, P. citrinopileatus, P. flabellatus, P. djamor, P. florida, P. sajor-caju, and P. ostreatus. Pleurotus pulmunarius is known to have the highest amount of β-glucan[25]. Some of the most common mushrooms and their medicinal properties are shown in Table 1 and represented in (Fig. 2).

      Table 1.  Common mushrooms and their medicinal properties.

      Medicinal mushroomPropertiesReferences
      Agaricus bisporusHypocholesterolemic and hypoglycaemic[21]
      Boletus edulis bullAntitumor[22]
      Flammulina velutipesAntioxidant, hypocholesterolemic and antiallergic[10]
      Grifola frondosaAntioxidant, hypotensive, hypoglycemic, immunotherapy, andanti-inflammatory activity[26]
      Ganoderma lucidiumHypoglycemic, antioxidant and antitumor, antiviral (HIV-1), antiallergic, anti-inflammatory, antihepatotoxic, cholesterol biosynthesis inhibitor, and antioxidative[23]
      Lentinula edodesAntioxidant, hypocholesterolemic, immunotherapy, antimicrobial, and antiprotozoal[10]
      Pleurotus ostreatusAntioxidant, hypocholesterolemic and antiallergic[24]

      Figure 2. 

      List of some edible mushrooms including their scientific names. Sources: by user Chris73, CC-BY-SA-3.0, https://commons.wikimedia.org/wiki/File:ChampignonMushroom.jpg; by user Sarefo, CC-BY-SA-3.0, https://commons.wikimedia.org/wiki/File:Ganoderma_applanatum_-_Lindsey.jpg; by user Jean-Pol, CC-BY-SA-3.0, https://upload.wikimedia.org/wikipedia/commons/f/f6/Pleurotus_ostreatus_JPG7.jpg; by user Siebot, CC-BY-SA-3.0, https://upload.wikimedia.org/wikipedia/commons/6/60/Eikhaas.JPG; by user Toter Alter Mann, CC-BY-SA-3.0, https://upload.wikimedia.org/wikipedia/commons/0/02/Boletopsis_nothofagi_fruitbodies.jpg; by user File upload Bot (Magnus Manske), CC-BY-SA-2.5, https://upload.wikimedia.org/wikipedia/commons/0/07/Cordyceps_Sinensis.jpg.

    • Mushrooms like Grifola frondose (maitake), Agaricus bisporus (button mushroom), Phellinus linteus (black hoof), Ophiocordyceps sinensis, and Agaricus blazei, show anti-diabetic and hypoglycemic activity. Bioactive compounds of Maitake mushroom (Grifola frondose), when administered orally to diabetic mice, reduces blood glucose level[26]. Polysaccharides extracted from Phellinus linteus were also reported to have anti-diabetic properties and show hypoglycaemic activity in non-obese mice with diabetes[27]. Polysaccharides such as β-glucans can increase insulin secretion, which reduces blood glucose levels[28]. β-glucans and glycoproteins isolated from Agaricus blazei showed hypoglycaemic activity in the streptozotocin-induced diabetic rat[29, 30]. Compounds such as flavonoids, phenols, terpenoids, tannins, alkaloids, glycosides, and saponins are present in Pleurotus florida, which have anti-diabetic properties.

    • Mitochondria play an essential role in adenosine triphosphate (ATP) production. When cells use O2 to create energy, different types of free radical oxygen species are generated, known as Reactive oxygen species (ROS). Examples of various biological free radicals are NO• (nitric oxide), LOO• (lipid peroxyl), OH• (hydroxyl), NO2• (nitrogen dioxide), OH− hydroxyl, ROO• (peroxyl), and various types of oxidants are H2O2 (hydrogen peroxide), LOOH (lipid peroxide), HNO2 (nitrous acid), N2O3 (dinitrogen trioxide), HOCl (hypochlorous acid), ONOO (peroxynitrite), 1O2 (singlet oxygen)[31]. When these free radicals are present in the human body at low concentrations, they can benefit the body as they play a role in cellular structure synthesis and immunity against microbial pathogens. When the production and concentration of oxygen-derived free radicals become uncontrollable, known as oxidative stress, it leads to many health complications[32]. Antioxidants control oxidative molecules to achieve balanced ROS homeostasis. Antioxidants are compounds that protect the cells against free radicals. It can be endogenous or exogenous (dietary supplements). Endogenous antioxidant compounds can be enzymatic such as catalase, glutathione peroxidase, and superoxide dismutase, or can be non-enzymatic, like melatonin. Vitamins also serve as antioxidants such as E and C. Other antioxidant molecules include carotenoids and thiol antioxidants like lipoic acid and glutathione[33]. Another fungal system, such as Aspergillus (non-edible), also contains thioredoxin, glutathione S-transferase, superoxide dismutase, and catalase, which is also involved in redox homeostasis[34].

    • Carbohydrates are the most potent substance in mushrooms, with immunomodulating and antitumor properties. Different types of carbohydrates such as fructose, mannitol, trehalose, glucose, rhamnose, arabinose, xylose, maltose, fucose, and mannose are found in mushrooms. The fungal cell wall contains β-glucan[35]. It is a critical bioactive element of mushrooms. Adaptogens and immune stimulators are their primary functions, along with immunomodulating, antioxidant, anticancer, neuroprotective, and anticholesterolemic activities[36]. The immunostimulatory action of mushroom polysaccharides is mostly preventative and belongs to non-invasive treatments, helping to avoid infectious illnesses and tumor metastases[21, 37]. These polysaccharides activate the immune response against pathogens.

    • Polyphenols are the most prevalent antioxidant in the diet and can be classified into different subgroups like flavonoids, phenolic acids, lignans, and stilbenes. Phenolic acids are one of the major phenolic compounds present in mushrooms. Hydroxycinnamic acids and hydroxybenzoic acids are the subgroups of phenolic compounds and are derived from cinnamic acid and benzoic acids, which are nonphenolic molecules[38]. Derivatives of benzoic acids like Protocatechuic, 5-sulphosalicylic, homogentisic, p-hydroxybenzoic, gentisic, syringic, vanillin, vanillic along with common derivatives of cinnamic acids like o-coumaric, p-coumaric, ferulic, 5-o-caffeoylquinic, 4-o-caffeoylquinic, 3-o-caffeoylquinic, caffeic and sinapic are also found in mushrooms[39]. The presence of tannic acids and ellagic acids was also reported[39]. Polyphenols show their antioxidant activity by directly interacting with free radicals or initiating different pathways like Nrf/ARE[40]. They promote cell survival, prevent tumor growth, trigger apoptosis, and fight against infections (bacterial and viral) by a different mechanism[41]. Flavonoids are abundant in edible mushrooms. They are divided into six subclasses flavonols, isoflavones, anthocyanidins, flavones, flavanones, and flavanols[38].

    • Edible mushrooms contain an enormous amount of vitamin C (L-ascorbic acid)[39]. Ascorbic acid is recognized as a highly effective reactive species (RS) scavenger. It demonstrates effective efficiency in preventing lipid peroxidation and also surpassing other plasma components[42]. A higher level of ascorbic acid has been found in certain mushrooms as compared to some fruits and vegetables, which are generally taken in a regular diet as a source of vitamins. Cantharellus cibarius contains 100 mg/100 g (DW) dry weight of vitamin C (ascorbic acid) in the methanolic extract reported by Kozarski et al.[43].

    • Mushrooms contain commonly four types of tocopherols (α, β, γ, and δ). Among all tocopherols, α is the biologically most active form[39]. Edible mushrooms contain substantially lower levels of tocopherols as compared to several grocery items that are suggested as good sources of Vitamin E[39]. 0.02 and 200 μg/100 g DW tocopherol level is present in some mushrooms[44].

    • Ergothioneine (ET) is an amino acid containing a sulphur atom. ET is mainly obtained via the diet, and mushrooms are reported to be a significant source of ergothioneine[45]. Mushrooms contain about 400−2,500 mg/g of dry weight. Edible mushrooms also show hepatoprotective activity. Secondary metabolites produced by various edible mushrooms, like phenolics, terpenes, steroids, and some compounds in their cell wall, show hepatoprotective activity. Extracts of Ganoderma lucidum, Phellinus rimosus, Pleurotus florida, and Pleurotus sajor-caju were reported to have antioxidant and hepatoprotective activity[46].

    • Cancer is globally recognized as a fatal disease, causing a significant number of deaths each year. According to the World Health Organization (WHO), approximately 10 million fatalities are attributed to cancer each year. In 2020, WHO reported several statistics regarding different types of cancer; Breast cancer: Approximately 2.2 million reported cases of breast cancer, resulting in 685,000 deaths; Lung cancer: About 2.21 million cases of lung cancer were noted, leading to 1,180,000 deaths; Colorectal cancer: Approximately 1.93 million cases were recorded with 935,000 deaths; Gastric cancer: 1.09 million reported cases of gastric cancer and causing 769,000 deaths (www.who.int). Mushrooms are a promising addition to a cancer-fighting diet approximately 200 species of edible higher basidiomycetes are reported to inhibit the growth of various cancerous cells. Recent studies in Japan, Korea, China, and the USA showed mushroom extracts have potential antitumor compounds[47].

      The active compounds are derived from cellular components and secondary metabolites of edible mushrooms. They have been shown to enhance host resistance for the treatment of cancer[48]. Some of the bioactive extracts isolated from mushrooms used in various cancer treatments are presented in Table 2. Medicinal mushrooms produce complex secondary metabolites such as polyketides, triterpenoids, phenolic, and steroids. These compounds found to be essential in the treatment of various health problems, including cancer. Some of the complex compounds like quinones, cerebrosides, isoflavones, catechol, amines, triacylglycerols, steroids, organic, organic germanium, and selenium are considered low molecular weight compounds ranging from 12−190 kDa[6467]. There are high molecular weight compounds ranging from 200−400 kDa, such as glycans, homopolymer, and heteropolymer glucan complexes[68]. Some antitumor compounds extracted from mushrooms are listed in Table 3.

      Table 2.  List of bioactive extracts isolated from mushrooms used in various cancer treatments.

      CancerBioactive extractsIn vitro studyIn vivo studyReferences
      BreastGanoderic acid
      Methanol extract
      Agaricus bisporus, Cordyceps sinensis, Ganoderma lucidum, Inonotus obliquus, Poriacocos
      Tricholoma mongolicum
      Agaricus bisporus, Ganoderma lucidum, Schizophyllum commune[4952]
      ColorectalMethanol extract Polysaccharide’s extract Grifola frondose, Inonotus oblicuus,
      Agaricus bisporis, Agaricus blazei
      Agaricus blazei[5355]
      GastricMethanol extract Agaricus blazei[50]
      LiverPolysaccharideAgaricus blazei, Coriolus versicolor Lentinan,
      Cordyceps sinenses
      Agaricus blazei, Ganoderma lucidum, Phellinus linteus, Schizophyluum commune[5659]
      LungEthanol extractAgaricus blazie, Ganoderma lucidum, Inonotus obliquus, Lentinula edodes Poria cocos[60]
      ProstateFruit body powder Ganoderma lucidum, Lentinula edodes, Phellinus linteus[6163]

      Table 3.  List of antitumor compounds extracted from various medicinal mushrooms.

      ClassAntitumor agentsMushroom speciesReferences
      QuinonesPanepoxydonePanus conchatus[69]
      Lentinus crinitus
      CycloepoxydonXylaria strain
      Clavilactones CB, CD and CACliticybe claviceps
      Quinone 490Agaricus bisporus
      AminesPutrescine-1,4-dicinnamidePholiota spumosa[70]
      IsoflavonesGenisteinFlammulina velupites[69]
      Triacylglycerols1-oleoyl-2-linoleoyl-3-palmitoylglycerolGrifola frondosa[69]
      SteroidsErgosterolGrifola frondose[69]
      Agaricus blazei
      Lucidenic lactone
      Cerevisterol
      Ganoderiol FGanoderma lucidum[7173]
      Ganodermanontriol
      Dehydroebriconic acidDaedaleadic kinsii[69]
      Organic germaniumBis-β-carboxyethylgermaniumsequioxideGanoderma lucidum[72]
      Homoglucans(1→3)- β-D-glucan with (1→6)-β-D branches: LentinumLentinus edodes[72]
      SchizophyllanSchizophyllum commune[74]
      GrifolanGrifola frondose[71,74]
      (1→3)-β-D-glucan with (1→2) or (1→6) branchesPachyman from poriacocos[37]
      (1→6)-β-D-glucan with (1→4)-α branchesAgaricus blazei[37]
      HeteroglucansGalactoxyloglucanHericiumerinaceus[72]
      MannogalactoglucanAgaricus blazei, Ganoderma lucidum
      XylogalactoglucanInonotuso bluquus
      GlycansGlucogalactanGanoderma tsugae[63]
      XylanHericium erinaceus[37]
      GlycoproteinsGalactoxyloglucan- protein complexHericinum erinaceus[74]
      GlycopeptidesPolysaccharide peptideTrametes versicolor[74]
      ProteoglycansGLISGanoderma lucidum[72]
      PLPhellinus linteus

      In addition to antitumor properties, mushrooms are currently utilized as meat analogs in the USA by various renowned companies cooperating with local food places and e-market platforms. Meat analogs such as Plant Plus’s meat dumplings, meat zongzi, and vegetarian beef meatballs have been introduced in such companies. Since edible mushrooms are a rich source of protein, there is an emerging field for producing edible mushroom meat analog proteins. A. bisporus, L. edodes, P. ostreatus, and C. comatus have been listed as raw material sources subjected to satisfy the artificial meat composites. The commercialization of edible mushroom meat analog proteins has been introduced as ‘pickled fish fillets’ made from H. erinaceus[75]. Furthermore, the application of mushrooms as medicinal agents has also been introduced during COVID-19 as an immune-stimulating agent. Studies are reviewed on the applicability of mushrooms as an adjuvant in vaccines. Still, due to the high risk of mortality during SARS-CoV-2 infection, this approach has yet to be implemented as allergic reactions from edible mushrooms to some individuals may interfere with the actual mechanism studied[76].

    • Mushrooms are very common in food and used since ancient times for their medicinal properties. Edible mushrooms are a potential functional food. It can be a good choice among people who trying to lose weight because of its low-calorie content. Due to its high protein and low-fat content, it increases the nutritional level and is good for muscle building. The presence of various bioactive compounds provides mushrooms with many medicinal and nutraceutical properties. It does not only provide macronutrients like carbohydrates and proteins but also provides various micronutrients which are required daily. Edible mushrooms can be considered as a good source of vitamins, especially vitamin D as it presents in high amounts in various species of mushrooms compared to various other food items. To supplement vitamin D during an infection such as in the COVID-19 pandemic, mushrooms could be a valuable source to boost the requirement for vitamin D. It is a good option for people who follow a vegan lifestyle and those who are lactose intolerant, and those who only consume egg and milk for daily vitamin D requirement. Mushrooms can also be used to treat chronic diseases. They can also be considered good antioxidant dietary supplements because of the various compounds present in them. As an antioxidant, it helps to reduce oxidative stress in the tissue due to the generation of ROS and it can be used to detoxify the ROS in cancer patients. Different metabolite extracts of medicinal mushrooms and their mode of action require further investigation.

    • The author acknowledges the research facility provided by the Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Solan, India.

      • The authors declare that they have no conflict of interest.

      • Copyright: © 2023 by the author(s). Published by Maximum Academic Press on behalf of Nanjing Agricultural University. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.
    Figure (2)  Table (3) References (76)
  • About this article
    Cite this article
    Rani M, Mondal SM, Kundu P, Thakur A, Chaudhary A, et al. 2023. Edible mushroom: occurrence, management and health benefits. Food Materials Research 3:21 doi: 10.48130/FMR-2023-0021
    Rani M, Mondal SM, Kundu P, Thakur A, Chaudhary A, et al. 2023. Edible mushroom: occurrence, management and health benefits. Food Materials Research 3:21 doi: 10.48130/FMR-2023-0021

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return